SpineVision, Inc. Reports 27% Boost In Y/E 2013 Sales To €10.5 Million

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ANTONY, France--(BUSINESS WIRE)--SpineVision®, a commercial-stage medical device company that designs, develops and markets products for the surgical treatment of spine disorders, announced today that its product sales for 2013 increased to €10.5 million, an increase of 27% compared with 2012.

Help employers find you! Check out all the jobs and post your resume.

Back to news